President and CEO
Claire is the Chief Executive Officer at the Alliance for Health Policy. She is a dynamic executive with more than 25 years of experience effectively engaging others to catalyze change in health care and health policy. Claire has served in leadership roles in associations, corporations, consulting and communications firms, including GMMB, the Blue Cross Blue Shield Association, Fleishman Hillard, the Generic Pharmaceutical Association (now AAM), Avalere, Alexion Pharmaceuticals, and others. In these roles, she has managed effective educational and engagement campaigns, introduced new capabilities, products and services, established novel cross-functional teams, and successfully achieved gains in reputational status, growth and audience impact. In her career, she has worked for organizations across the spectrum in health care ranging from scientific discovery to public health to patient advocacy. These include non-profits like the Robert Wood Johnson Foundation, The Bill and Melinda Gates Foundation, and National Health Council; medical leaders like the American Academy of Family Physicians, the International Society for Stem Cell Research and Mayo Clinic; and companies like Biogen, Cigna, and Siemens Health. Claire is a graduate of the University of Illinois at Champaign-Urbana, where she served a semester as a research assistant to a member of UK parliament, and a co-founder of the campus sketch comedy troupe. She also holds an MSc. with Distinction from the London School of Economics in Media and Communications, where her dissertation focused on the construct of public opinion within the halls of the U.S. Congress. Claire also served as an adjunct professor at Johns Hopkins University, teaching students in the Communications MA program. She is the mother of two children, a cancer survivor, and serves as a Director on the Fairfax Library Foundation Board.
Tanisha Carino, Ph.D.
Tanisha Carino, Ph.D. is a partner with the Brunswick Group, an advisory firm that helps clients navigate the interconnected financial, political, and social worlds to build trusted relationships with all their stakeholders. She is a corporate affairs and health policy expert who brings over 20 years of experience across multiple healthcare leadership positions in government, private, and non-profit sectors. Prior to joining Brunswick, Tanisha held executive roles as the first Chief Corporate Affairs Officer of Alexion, Executive Director of FasterCures/Milken Institute, led US public policy at GlaxoSmithKline, and was the head of life sciences strategic advisory services for Avalere Health. She began her career as an HIV case worker in Atlanta and a policy researcher in the Medicare program. Dr. Carino is a Fulbright Fellow, has served as a Visiting Fellow for the White House Office of Science and Technology Policy, and earned her doctorate in health policy from Johns Hopkins University. She is associate faculty at the Johns Hopkins Bloomberg School of Public Health, a Visiting Fellow for the Duke-Margolis Health Policy Center, serves on the Board of Directors of Silk Road Medical, One Mind, and is the Vice-Chair of the Alliance for Health Policy.
Adaeze Enekwechi, Ph.D., MPP
Adaeze Enekwechi is an operating partner at Welsh, Carson, Anderson and Stowe, an investment firm where she focuses on growth-oriented healthcare companies. She also brings a focus on the policy and regulatory environment which can have an outsize impact on healthcare investments. Dr. Enekwechi is trained in healthcare economics and outcomes research, and led IMPAQ, LLC, a company that provided research, technical assistance, and advanced analytics services for government clients which she took through its acquisition in 2020. In addition to her private sector experience, she spent many years in federal policy roles at the Congressional Budget Office (CBO), the Medicare Payment Advisory Commission (MedPAC) and as the head of Health Programs at the White House Office of Management and Budget (OMB) under President Obama. There she led policy, management and regulatory oversight for over $1 trillion in spending across all federal health agencies and programs. Dr. Enekwechi also serves on the board of directors at the Public Health Institute, UnityPoint Health System, and Tia, a women’s health company.
Dianne Faup, J.D.
Dianne Faup is a founding partner at Speire Healthcare Strategies, a boutique healthcare consulting firm that provides strategic advisory services at the intersection of policy and strategy. She has over 25 years of experience working in the health care industry as an attorney, a management consultant, and a government executive. Previously, she held senior leadership positions in Booz Allen Hamilton and KPMG Europe and served as a senior advisor to then-Deputy Secretary Alex Azar of the U.S. Department of Health & Human Services and chief of staff of the District of Columbia Department of Health Care Finance. Ms. Faup holds a bachelor’s degree in management from Manhattanville College and a juris doctorate from the University of New Hampshire (Franklin Pierce Law).
Vicky Gregg has a deep experience in health care ranging from direct patient care to her long tenure as a chief executive spans hospital administration, long-term care, and health care benefits and financing. Currently she is a co-founder of Guidon Partners, GP, LLC since November 2014. Ms. Gregg served as the chief executive officer of BlueCross BlueShield of Tennessee from January 2003 to December 2012. She served as market vice president for Humana in Kentucky, Ohio, and Indiana prior to joining BlueCross. Ms. Gregg was appointed by Senate Majority Leader Bill Frist to the National Institutes of Health Commission on Systemic Interoperability, served on the Boards of the BlueCross BlueShield Association and America’s Health Insurance Plans, including two years as Chair, the National Institute of Healthcare Management (NIHCM), and the Board of the University of Tennessee.
Vice-Chair & Secretary
Elizabeth Hall is the vice president of public policy and issues management at Elevance Health. Ms. Hall and her staff work closely with business unit leaders, senior executives, and internal subject matter experts to develop enterprise positions on federal and state legislation as well as federal regulations related to our core business. From 2010 – 2021, she served as the company’s vice president of Federal Affairs. Prior to joining Elevance Health, Ms. Hall served as the director of the Office of Legislation at the Centers for Medicare & Medicaid Services at the U.S. Department of Health and Human Services. She also worked for Sen. Bill Frist (R-Tenn.) in Congress. She has a bachelor’s in sociology from the University of Pennsylvania.
Demetrios L. Kouzoukas
Demetrios L. Kouzoukas has deep experience in every health care sector and spanning business, law, and government. He is a partner at the Team8 Health venture foundry, a member of the Board of Directors of Clover Health, director of Paragon Health Institute’s Medicare Initiative, and a member of the American Medical Association Digital Medicine Payment Advisory Group. From 2017 to 2021, Kouzoukas served as the chief executive of the Medicare program at the Centers for Medicare and Medicaid Services (CMS). In that role, he worked with patients, policymakers, providers, insurers, and manufacturers to improve health care in the United States. Prior to joining CMS, Demetrios was a senior executive at UnitedHealthcare’s Medicare business. He has also served as Principal Associate Deputy Secretary and as Deputy General Counsel of the U.S. Department of Health and Human Services, working with every part of the Department’s portfolio. He has built innovative practices focused on new regulations and business models at two leading health care law firms. In addition, he has represented the public as an expert in public administration and health benefits as an appointee to the Administrative Conference of the United States.
Margaret A. Murray
Margaret Murray is the founding CEO of the Association for Community Affiliated Plans (ACAP). Prior to leading ACAP, Mrs. Murray was the Medicaid director in New Jersey and oversaw the expansion of the FamilyCare program to cover all children under 350 percent of poverty. She was also a senior budget analyst for the U.S. Office of Management and Budget. She has served the Institute of Medicine’s Committee on the Public Financing and Delivery of HIV Care, the Maryland Community Health Resources Commission and on the board of a Community Health Center in Southern Maryland. She received her master’s in public affairs from the Woodrow Wilson School of Princeton University and her bachelor’s cum laude in economics and classical civilization from Wellesley College.
Dan Mendelson, MPP
Dan Mendelson is CEO, Morgan Health, of JPMorgan Chase & Co. He was previously founder and CEO of Avalere Health, a healthcare advisory company based in Washington D.C. Dan also served as operating partner at Welsh Carson, a private equity firm. Before founding Avalere, Dan served as associate director for Health at the Office of Management and Budget in the Clinton White House. Dan currently serves on the board of Champions Oncology (CSBR) and is adjunct professor at the Georgetown University McDonough School of Business. He previously served on the boards of Coventry Healthcare, HMS Holdings, Pharmerica, Partners in Primary Care, Centrexion, and Audacious Inquiry. He holds a bachelor’s from Oberlin College, and a master’s in public policy from the Kennedy School of Government at Harvard University.
Mike Park, J.D., MPH
Mike Park is a partner in Alston & Bird’s Health Care Legislative & Public Policy Group. He has more than 20 years of health law and policy experience. He focuses his practice on representing health care providers, insurers, and manufacturers before Congress and the administration on a wide range of health care legislative and regulatory issues and also counsels clients in connection with congressional investigations. Before joining Alston & Bird, Mr. Park served as health policy counsel to Senator Charles Grassley (R-IA) during his tenure as Chairman of the Senate Committee on Finance, where he developed legislation on issues including Medicare payment policy, health information technology, and program integrity and conducted congressional investigations on public and private health care stakeholders. Mr. Park also served as a policy coordinator in the U.S. Department of Health and Human Services Office of the Secretary, as a project officer for Medicare payment demonstration programs at the Centers for Medicare & Medicaid Services, and as a health research analyst at the Center for Studying Health System Change. He currently serves as an adjunct faculty member at George Washington University’s School of Public Health. He received his bachelor’s degree from Connecticut College, his juris doctorate degree from Penn State Dickinson School of Law, and his master’s in public health from Columbia University.
Cynthia Rice, MPP
As a non-profit executive, senior government policy official, and patient advocacy leader for more than three decades, Cynthia Rice has advanced numerous innovative initiatives to improve healthcare and strengthen communities. Most recently, Ms. Rice served as Chief Mission Strategy Officer for JDRF, accelerating the development and access to life-changing breakthroughs for people with type 1 diabetes and strengthening the organization’s capacity to advance its mission. In government, Ms. Rice served at the White House, leading a team at the Domestic Policy Council, and in the U.S. Senate, advising two members of the Senate Finance Committee on healthcare, budget, and social policies. In these and other roles, Ms. Rice worked closely with leaders in Congress, the executive branch, foundations, advocacy organizations, research institutions, the clinical community, private insurance companies, and companies as well as networks of volunteers. Ms. Rice has a master’s degree in public policy from the University of California at Berkeley and a bachelor’s degree from Harvard University.
Marc Samuels, J.D., MPH
Marc Samuels is founder and CEO of ADVI Health, a health care and life sciences advisory and consulting services firm headquartered in Washington, DC that helps clients accelerate growth, trailblaze innovation, and expand coverage of products and services. Marc also founded the firm’s life science accelerator, adviLAB, to invest in digital therapy, AI, MedTech, and cell and gene therapy clients in early stages of development. Marc has played a role in over 200 product and service projects over the last two decades from cell and gene, to rare and ultra-rare to oncology, and digital therapies. Marc has worked widely across the US health care system to improve regulatory and payer policy, promote appropriate clinical outcomes, and highlight the importance of the patient experience. Before founding ADVI, Marc was a partner in HillCo Partners, an Austin-based public affairs and advocacy company. He served both President George W. Bush and George H.W. Bush at the Texas Health and Human Services Commission, the Governor’s Policy Office, the Vice President’s Council on Competitiveness, and the White House Office of Policy Development, respectively. Marc began his career as an HIV researcher at the Midwest AIDS Behavioral Research Center in Ann Arbor. Marc speaks frequently on business strategy and policy matters. His comments and analyses have appeared in STAT News, The Pink Sheet, Fierce Healthcare, the Journal of Oncology Practice, Medical Economics, among other places. Marc earned his juris doctorate at the University of Texas, a master’s in public health from Yale School of Public Health, and a bachelor’s degree in neuropsychology from the University of Michigan. Marc is a visiting fellow at the Duke-Margolis Center for Health Policy, serves on the Board of Directors of NCCN Foundation, and is on the Advisory Board of the UCSF Rosenman Institute where he co-developed the Rosenman ADAPT and RISE programs, the later specifically created to advise and support founders from underrepresented groups to make the launch and scale of their health tech, digital or life science innovation as successful as possible.
Kirsten Sloan is senior policy director at the American Cancer Society Cancer Action Network. She leads ACS CAN ‘s policy work in support of the organization ‘s extensive federal, state, and local advocacy agendas. In addition, she manages a team of senior policy principals and analysts with a focus on access to care, emerging science, and prevention. Kirsten came to ACS CAN from the National Partnership for Women & Families, where she served as the vice president and helped manage the organization ‘s health policy portfolio. Before working for the National Partnership, she was director of federal health issues for AARP, leading advocacy efforts around Medicare and health care. Kirsten is a graduate of the University of Washington in Seattle.
Ladd Wiley, J.D.
Ladd Wiley leads the Public Policy team at Epic and is a member of Epic’s Board of Directors. Prior to joining Epic, Ladd was in private practice in Washington, DC working in health policy. He is an expert in the Senate confirmation process and has guided numerous cabinet level and agency heads through that process. Ladd has extensive experience in government leadership and health policy. He previously served as HHS’ Principal Deputy General Counsel and Counselor to the HHS Secretary. Before that, he was Chief Counsel to the Governor of Wisconsin.
M. Roy Wilson, M.D., M.S.
M. Roy Wilson is the president of Wayne State University. Prior to joining Wayne State, Dr. Wilson served as deputy director for strategic scientific planning and program coordination at the National Institute on Minority Health and Health Disparities (NIMHD) of the National Institutes of Health (NIH). Previously, Dr. Wilson was dean of the School of Medicine and vice president for health sciences at Creighton University, president of the Texas Tech University Health Sciences Center, chancellor of the University of Colorado Denver/Anschutz Medical Campus and chair of the Board of Directors of University of Colorado Hospital. Dr. Wilson received his undergraduate degree from Allegheny College, a master’s degree in epidemiology from the University of California, Los Angeles, and a medical doctorate from Harvard Medical School.